Company profile for Uniqure

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

uniQure is delivering on the promise of gene therapy -- single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with hemophilia, Huntington’s disease and other severe genetic diseases. We are advancing a focused pipeline of innovative gene therapies. We are currently condu...
uniQure is delivering on the promise of gene therapy -- single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with hemophilia, Huntington’s disease and other severe genetic diseases. We are advancing a focused pipeline of innovative gene therapies. We are currently conducting a pivotal phase 3 trial in our lead indication, hemophilia B, and have initiated a phase 1/2 trial in Huntington’s disease.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Netherlands
Address
Address
Paasheuvelweg 25a 1105BP Amsterdam
Telephone
Telephone
+1 339 970 7000
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.biospace.com/fda/fda-reversals-send-uniqure-biohaven-capricor-more-into-a-tailspin

BIOSPACE
24 Nov 2025

https://www.globenewswire.com/news-release/2025/11/10/3184405/0/en/uniQure-Announces-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
10 Nov 2025

https://www.biospace.com/drug-development/fda-does-about-face-on-uniqures-huntingtons-gene-therapy

BIOSPACE
03 Nov 2025

https://www.biospace.com/drug-development/uniqures-huntingtons-breakthrough-brings-hope-to-patients-but-experts-urge-caution

BIOSPACE
27 Oct 2025

https://www.globenewswire.com/news-release/2025/09/29/3158102/0/en/uniQure-Announces-Closing-of-Upsized-Public-Offering-and-Full-Exercise-by-Underwriters-of-Option-to-Purchase-Additional-Shares.html

GLOBENEWSWIRE
29 Sep 2025

https://www.globenewswire.com/news-release/2025/09/24/3155348/0/en/uniQure-Announces-Positive-Topline-Results-from-Pivotal-Phase-I-II-Study-of-AMT-130-in-Patients-with-Huntington-s-Disease.html

GLOBENEWSWIRE
24 Sep 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty